Company Study of Beijing Tiantan Biological Products Co., Ltd, 2012
- Language: Chinese
- 12 Pages
- Published: May 2012
- Region: China
Beijing Tiantan Biological Products Co., Ltd, a listed company funded by Beijing Biological Preparations Research Institute via stripping off its main operating assets in 1998, specializes in research, production and operation of biological products like vaccine, blood preparations, diagnosis equipment, and now its share holder is China National Biotec Group. With the company development, now it has several holding subsidiaries like Changchun Qifu Biological Products Co., Ltd.
It has over 110 Biological Products,, including Hepatitis B vaccine, Polio vaccine, MMR Vaccine, Encephalitis vaccine, Influenza vaccine, Varicella vaccine, human albumin, PH4, and so on. Beijing Tiantan Biological Products Co., Ltd. is the important production base for China’s EPI vaccine.
1 Profile
2 Operation
3 Revenue Structure
4 Gross Margin
5 Client and Supplier
6 Operation of Vaccine Business
Selected Charts:
Major Shareholding Companies of Tiantan Biological and their Operating Revenue, Net Profit (Unit: RMB mln)
Operating Revenue and Total Profit of Beijing Tiantan Biological, 2006-2011
Revenue Breakdown of Beijing Tiantan Biological by Products, 2007-2011
Revenue Breakdown of Beijing Tiantan Biological by Region, 2007-2011 (Unit: RMB mln)
Gross Profit Margin of Beijing Tiantan Biological by Products, 2007-2011
Procurement Value and Its Proportion of Top5 Suppliers of Beijing Tiantan Biological, 2007-2011
Revenue and Its Proportion of Beijing Tiantan Biological’s Top5 Clients,2007-2011
Top5 Clients and Their Revenue of Beijing Tiantan Biological
Vaccine Revenue and Gross Margin of Beijing Tiantan Biological, 2007-2011(Unit:RMB mIn)
Lot Release Quantity and Proportion of Beijing Tiantan Biological by Products, 2009-2011
| Format | Properties | |
|---|---|---|
| Electronic (PDF) | The report will be emailed to you. The report is sent in PDF format. | This is a single user license, allowing one specific user access to the product. |
| Hard Copy | A printed copy of the report will be shipped to you. | |
| Enterprisewide | The report will be emailed to you. The report is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |